Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Guided Therapeutics's price to sales ratio was 23.8× on Oct 19, 2026, against 180.7× a year earlier. Over the last 5 years it ranged from 0.1× to 381.1×, with a median of 110.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 23.8× | −229.8 |
| 2025 | Dec 31, 2025 | 253.6× | +15.0 |
| 2024 | Dec 31, 2024 | 238.7× | +117.2 |
| 2023 | Dec 29, 2023 | 121.4× | +8.1 |
| 2022 | Dec 30, 2022 | 113.3× | −58.2 |
| 2021 | Dec 31, 2021 | 171.6× | – |
See a number that looks wrong?